André Tomlin considers the recommendations for health service delivery and research from the recent Mindful Nation report.
[read the full story...]
André Tomlin considers the recommendations for health service delivery and research from the recent Mindful Nation report.
[read the full story...]
John Baker summarises a recent Cochrane systematic review of psychosocial interventions for benzodiazepine harmful use, abuse or dependence.
[read the full story...]
Join a diverse group of mental health service users, researchers, practitioners and developers to discuss this vital issue. We are debating this question in a #Mindtech15 fringe event taking place in London (and on Twitter) at 7pm on Wednesday 2nd December.
[read the full story...]
Emily Stapley summarises a recent RCT of a cognitive behavioural prevention programme for young people at risk of depression.
[read the full story...]
Another debut blog today, this time from Suzanne Dash, who presents the results of the REEACT trial published last week in the BMJ. The study found limited uptake of computerised CBT by people with clinical depression and no benefit of free or commercially available cCBT packages over usual GP care.
[read the full story...]
Ioana Cristea considers the possible causes responsible for the apparent narrowing of the drug-placebo gap, which over the last 30 years has seen estimates of depression symptom reduction from antidepressants fall from 70% to 30%.
[read the full story...]
Karina Lovell appraises the first UK RCT of computerised cognitive behavioural therapy (cCBT) for depression in children and young people, which shows a clinically meaningful improvement in depression and anxiety.
[read the full story...]
Alex Langford reflects on the media hype surrounding a new RCT of the NAVIGATE intervention; a comprehensive, multidisciplinary, team-based treatment approach for first episode psychosis.
[read the full story...]
Leen Vereenooghe summarises a systematic review of the use of CBT (cognitive behavioural therapy) to treat depression in people with learning disabilities.
[read the full story...]
Dan-Mikael Ellingsen explores the neurochemistry of placebo effects in major depression, as he reviews a recent study of the association between placebo-activated neural systems and antidepressant responses.
[read the full story...]